Jim W. Larrick
Fondatore presso Quality Clinical Labs, Inc.
Profilo
Jim W.
Larrick is the founder of Tecan Genomics, Inc. (2000), Adamas Pharmaceuticals LLC (2000), PanGenetics BV (1995), ChinaBio LLC (2007), Velocity Pharmaceutical Development LLC (2011), and Neuromolecular Pharmaceuticals, Inc., Absalus, Inc., Quality Clinical Labs, Inc., Velocity Pharmaceutical Holdings LLC.
He is currently the Chairman of Theron Pharmaceuticals, Inc., Director & Chief Scientific Officer of Eumentis Therapeutics, Inc., and Chief Scientific Officer & Vice President of Planet Biotechnology, Inc. He previously held positions as Director at Genelabs Technologies, Inc., Venture Partner at Presidio Partners, and Biotech Investment Committee Co-Chair at Life Science Angels.
Dr. Larrick received a doctorate degree from Duke University.
Posizioni attive di Jim W. Larrick
Società | Posizione | Inizio |
---|---|---|
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Direttore Tecnico/Scientifico/R&S | - |
Quality Clinical Labs, Inc.
Quality Clinical Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SRI International, Quality Clinical Labs, Inc. is a company that performs clinical pathology analyses. The company is based in Mountain View, CA. The company was founded by Jim W. Larrick. Quality Clinical Labs was acquired by SRI International on April 24, 2006. | Fondatore | - |
Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Presidente | 17/05/2011 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Fondatore | 01/01/2011 |
Eumentis Therapeutics, Inc.
Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jim W. Larrick
Società | Posizione | Fine |
---|---|---|
Neuromolecular Pharmaceuticals, Inc. | Fondatore | 16/07/2008 |
Absalus, Inc. | Fondatore | 16/07/2008 |
Velocity Pharmaceutical Holdings LLC
Velocity Pharmaceutical Holdings LLC Financial ConglomeratesFinance Velocity Pharmaceutical Holdings LLC operates as a holding American company. | Fondatore | - |
ADAMAS PHARMACEUTICALS, INC. | Fondatore | - |
░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | - |
Formazione di Jim W. Larrick
Duke University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 16 |
---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Tecan Genomics, Inc.
Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA. | Electronic Technology |
Medlogics Device Corp.
Medlogics Device Corp. Pharmaceuticals: MajorHealth Technology Medlogics Device Corp. was engages in the research, development and manufacture of drug eluting coating, stent and catheter solutions. The company was founded in August 2002 and headquartered in Santa Rosa, CA. | Health Technology |
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
Neuromolecular Pharmaceuticals, Inc. | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Finance |
Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc. BiotechnologyHealth Technology Theron Pharmaceuticals, Inc. provides treatments for COPD and asthma. It is a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. The firm’s product TRN-157, a preclinical development therapy focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded by M. Venkatraman, Xiaoming Zhang and Jurg Pfister in 2008 and is headquartered in Sunnyvale, CA. | Health Technology |
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
Presidio Partners
Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Finance |
Absalus, Inc. | Health Technology |
Quality Clinical Labs, Inc.
Quality Clinical Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SRI International, Quality Clinical Labs, Inc. is a company that performs clinical pathology analyses. The company is based in Mountain View, CA. The company was founded by Jim W. Larrick. Quality Clinical Labs was acquired by SRI International on April 24, 2006. | Commercial Services |
Life Science Angels
Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Finance |
Velocity Pharmaceutical Holdings LLC
Velocity Pharmaceutical Holdings LLC Financial ConglomeratesFinance Velocity Pharmaceutical Holdings LLC operates as a holding American company. | Finance |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Retail Trade |
Eumentis Therapeutics, Inc.
Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Jim W. Larrick